TBRC Reports: Production of New Insulin Biosimilars is The Latest Trend in The Market, as Seen With Biocon`s Newly FDA Approved Semglee

Cision Ltd. is a public relations and earned media software company and services provider. On June 19, 2020, it released an article on the biosimilars market, sourced from TBRC`S Global Biosimilars Market report. The biosimilars market covered in this report is segmented by product into recombinant non-glycosylated proteins; recombinant glycosylated proteins.

Call Us

+1 3156230293

(Americas)

+44 2071930708

(Europe)

+91 8897263534

(Asia & Others)